Pharmacologic

• Lisdexamfetamine (50-70 mg/day) -- emerging treatment option
  • Cessation rate of binge eating episodes was double (42.2-50.0%) that of placebo (21.3%)
  • Study published in JAMA Psychiatry Mar 2015: http://www.ncbi.nlm.nih.gov/pubmed/25587645?dopt=Abstract

 

 

Content on this page has not been checked for accuracy. The author's credentials have not been confirmed. Always use multiple peer-reviewed scholarly sources and good clinical judgement in your decision making.

The Compendium platform was created by David Kwinter, MD, CCFP(EM).